Abstract
Tumor development involves alterations in DNA methylation patterns, which include both gains (hypermethylation) and losses (hypomethylation) in different genomic regions. The mechanisms underlying these two opposite, yet co-existing, alterations in tumors remain unclear. While studying the human MAGEA6/GABRA3 gene locus, we observed that DNA hypomethylation in tumor cells can lead to the activation of a long transcript (CT-GABRA3) that overlaps downstream promoters (GABRQ and GABRA3) and triggers their hypermethylation. Overlapped promoters displayed increases in H3K36me3, a histone mark deposited during transcriptional elongation and known to stimulate de novo DNA methylation. Consistent with such a processive mechanism, increases in H3K36me3 and DNA methylation were observed over the entire region covered by the CT-GABRA3 overlapping transcript. Importantly, experimental induction of CT-GABRA3 by depletion of DNMT1 DNA methyltransferase, resulted in a similar pattern of regional DNA hypermethylation. Bioinformatics analyses in lung cancer datasets identified other genomic loci displaying this process of coupled DNA hypo/hypermethylation, and some of these included tumor suppressor genes, e.g. RERG and PTPRO. Together, our work reveals that focal DNA hypomethylation in tumors can indirectly contribute to hypermethylation of nearby promoters through activation of overlapping transcription, and establishes therefore an unsuspected connection between these two opposite epigenetic alterations.
Highlights
Tumor development involves alterations in DNA methylation patterns, which include both gains and losses in different genomic regions
We demonstrated the existence of a bidirectional promoter (MAGEA6/concurrent upregulation of MAGEA6 and (CT-)GABRA3)
MAGEA6 and CT-GABRA3 become aberrantly co-activated in a significant proportion of tumors, including melanoma, and our previous studies indicated that this was caused by DNA demethylation of the MAGEA6/CT-GABRA3 promoter[15,16]
Summary
Tumor development involves alterations in DNA methylation patterns, which include both gains (hypermethylation) and losses (hypomethylation) in different genomic regions. The mechanisms underlying these two opposite, yet co-existing, alterations in tumors remain unclear. H3K36me[3], a histone mark deposited during transcriptional elongation and known to stimulate de novo DNA methylation Consistent with such a processive mechanism, increases in H3K36me[3] and DNA methylation were observed over the entire region covered by the CT-GABRA3 overlapping transcript. Our work reveals that focal DNA hypomethylation in tumors can indirectly contribute to hypermethylation of nearby promoters through activation of overlapping transcription, and establishes an unsuspected connection between these two opposite epigenetic alterations. Epigenetic alterations concern in particular DNA methylation, a chemical modification of cytosines in CpG sequences that is associated with long-term transcriptional
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have